|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 292.8 INR | +0.64% |
|
-9.83% | +16.88% |
| May. 24 | INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh | RE |
| May. 24 | Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea | MT |
BENGALURU (Reuters) - Indian drugmaker Biocon Ltd on Monday named Peter Bains as the group's chief executive officer.
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Shailesh Kuber)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,748 PTS | -1.42% | -0.25% | - | ||
| 292.8 INR | +0.64% | -9.83% | 4.45B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +16.88% | 4.45B | |
| +16.73% | 121B | |
| +13.04% | 107B | |
| -5.80% | 24.82B | |
| +1.69% | 22.48B | |
| -10.09% | 18.32B | |
| -40.52% | 16.33B | |
| -14.00% | 15.31B | |
| +1.18% | 14.08B | |
| +24.18% | 11.74B |
BIOCON LIMITED 
